Consort Medical plc (CSRT.L) (LON:CSRT – Get Rating) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,010 ($12.56) and traded as high as GBX 1,010 ($12.56). Consort Medical plc (CSRT.L) shares last traded at GBX 1,010 ($12.56), with a volume of 768 shares changing hands.
Consort Medical plc (CSRT.L) Stock Up 0.5 %
The company has a debt-to-equity ratio of 55.58, a quick ratio of 1.16 and a current ratio of 1.83. The stock has a market cap of £504.60 million and a P/E ratio of 127.85. The stock’s fifty day simple moving average is GBX 1,010 and its 200-day simple moving average is GBX 1,010.
About Consort Medical plc (CSRT.L)
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.
Read More
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Consort Medical plc (CSRT.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc (CSRT.L) and related companies with MarketBeat.com's FREE daily email newsletter.